background
respons
novel
influenza
outbreak
ny
citi
area
patient
sampl
submit
period
total
viral
diagnost
test
includ
rapid
antigen
direct
immunofluoresc
dfa
viral
cultur
pcr
littl
known
perform
assay
detect
novel
background
season
circul
respiratori
virus
addit
subtyp
influenza
becam
critic
identif
high
risk
andor
hospit
patient
novel
infect
monitor
spread
outbreak
studi
design
studi
analyz
perform
binaxnow
influenza
b
test
binaxnow
rapid
detect
flu
b
test
b
direct
immunofluoresc
rmix
cultur
luminex
xtag
respiratori
viru
panel
rvp
detect
season
influenza
novel
respiratori
virus
rvp
also
evalu
abil
differenti
season
novel
result
sensit
specif
ppv
npv
detect
novel
determin
compar
fourtest
method
rapid
antigen
dfa
rmix
cultur
rvp
individu
sensit
binaxnow
b
compar
rmix
cultur
detect
novel
respect
unsubtyp
influenza
specimen
identifi
rvp
test
cdc
novel
specif
rtpcr
assay
confirm
novel
conclus
rapid
antigen
test
dfa
rmix
cultur
xtag
rvp
test
detect
novel
strain
highli
vari
sensit
rvp
test
provid
best
diagnost
option
rvp
demonstr
superior
sensit
detect
influenza
strain
includ
novel
provid
accur
influenza
subtyp
identifi
signific
number
addit
respiratori
pathogen
weekend
april
high
school
student
preparatori
school
queen
ny
evalu
emerg
room
long
island
jewish
medic
center
new
hyde
park
ny
north
shore
univers
hospit
manhasset
ny
complaint
flulik
symptom
due
recent
travel
sever
student
cancun
mexico
week
previou
high
concern
infect
novel
influenza
strain
nasopharyng
swab
obtain
sent
hospit
laboratori
rapid
antigen
screen
test
influenza
influenza
b
virus
initi
specimen
test
rapid
antigen
posit
influenza
sent
via
new
york
citi
height
normal
respiratori
viru
season
laboratori
gener
perform
approxim
test
day
day
prior
outbreak
number
viral
test
perform
regular
influenza
season
end
weekend
initi
influenza
test
surg
high
viral
test
perform
singl
day
second
surg
influenza
outbreak
week
later
day
high
viral
test
perform
accord
hospit
test
polici
nasopharyng
np
sampl
initi
screen
rapid
antigen
test
local
hospit
due
suboptim
perform
rapid
antigen
test
sampl
neg
influenza
b
refer
north
shorelij
health
system
clinic
virolog
laboratori
dfa
rmix
viral
cultur
howev
first
sever
day
outbreak
appar
laboratori
need
provid
influenza
subtyp
inform
thu
abl
quickli
identifi
potenti
case
novel
therefor
initi
sampl
patient
high
risk
exposur
novel
preparatori
school
student
sibl
teacher
person
recent
travel
mexico
patient
admit
hospit
flulik
ill
outreach
patient
influenza
aposit
rapid
antigen
test
dfa
andor
rmix
cultur
test
rvp
assay
prior
onset
influenza
epidem
rvp
assay
use
select
case
viru
surveil
research
studi
intent
fulli
convert
respiratori
viru
test
rvp
assay
summer
month
food
drug
administr
fda
clear
version
rvp
assay
detect
virus
includ
adenoviru
human
metapneumoviru
hmpv
parainfluenza
virus
rhinoviru
respiratori
syncyti
virus
rsv
b
influenza
influenza
b
addit
detect
influenza
matrix
gene
rvp
assay
also
abil
subtyp
influenza
hemagglutinin
gene
season
sampl
posit
matrix
gene
neg
season
consid
influenza
unsubtyp
potenti
novel
strain
influenza
research
useonli
version
assay
also
includ
detect
parainfluenza
type
coronavirus
sinc
rvp
assay
abl
subtyp
influenza
season
virus
detect
broad
rang
respiratori
virus
influenza
made
rvp
test
broadli
avail
immedi
basi
week
follow
start
outbreak
overwhelm
number
test
request
requir
continu
modif
laboratori
test
protocol
test
algorithm
includ
variou
combin
rapid
antigen
test
dfa
viral
cultur
rvp
chang
frequent
deal
surg
patient
test
priorit
test
admit
patient
provid
clinic
relev
inform
public
health
offici
due
uniqu
novel
strain
rel
perform
variou
diagnost
test
detect
novel
known
begin
influenza
outbreak
purpos
studi
evalu
perform
rapid
antigen
test
dfa
rmix
cultur
rvp
assay
detect
novel
background
season
common
circul
respiratori
virus
sampl
patient
evalu
influenza
like
ill
hospit
set
emerg
depart
inpati
n
outpati
n
includ
studi
patient
rang
age
day
year
sampl
type
test
includ
flock
nasopharyng
np
swab
copan
murrieta
ca
submit
univers
transport
media
utm
dhi
np
aspir
np
wash
sampl
store
refriger
frozen
c
test
sampl
collect
per
standard
care
routin
diagnost
test
inform
consent
therefor
requir
rapid
antigen
test
perform
neat
sampl
sampl
dfa
rmix
cultur
process
accord
standard
laboratori
procedur
nucleic
acid
test
rvp
assay
influenza
subtyp
confirm
extract
l
aliquot
respiratori
sampl
use
nuclisen
easymag
extract
platform
biomerieux
durham
nc
accord
manufactur
instruct
nucleic
acid
store
c
test
test
perform
accord
manufactur
instruct
laboratori
valid
protocol
total
number
sampl
test
follow
number
result
avail
determin
perform
diagnost
test
detect
season
novel
influenza
virus
rapid
antigen
test
n
use
binaxnow
n
b
n
dfa
use
respiratori
viru
reagent
n
rmix
viral
cultur
n
rvp
assay
n
although
initi
set
sampl
sent
center
diseas
control
first
patient
evalu
novel
system
emerg
room
sampl
previous
subtyp
rvp
assay
laboratori
compel
need
evalu
rvp
subtyp
subsequ
set
sampl
earli
deploy
assay
accordingli
subset
sampl
identifi
rvp
unsubtyp
influenza
n
contain
suffici
viral
titer
confirm
novel
new
york
state
laboratori
viral
diseas
wadsworth
center
albani
ny
previous
describ
addit
rvp
sampl
n
classifi
season
unsubtyp
influenza
test
either
state
depart
health
inhous
laboratori
valid
assay
use
method
develop
cdc
confirm
novel
strain
due
massiv
influx
test
sampl
chang
test
algorithm
outbreak
sampl
test
method
comparison
therefor
made
base
upon
test
method
use
evalu
specimen
exampl
compar
perform
tradit
test
method
result
avail
rapid
antigen
test
dfa
rmix
cultur
set
sampl
specif
separ
sampl
set
use
compar
binaxnow
result
result
dfa
n
rmix
cultur
n
compar
b
test
result
dfa
n
rmix
cultur
n
analysi
rvp
data
present
separ
sinc
origin
sampl
test
rvp
specif
select
base
upon
posit
rapid
antigen
dfa
cultur
result
therefor
direct
comparison
includ
sampl
would
bias
increas
detect
rate
assay
data
unbias
subset
sampl
test
rapid
antigen
dfa
rmix
cultur
rvp
compar
accur
reflect
comparison
four
test
method
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
calcul
use
standard
formula
differ
perform
variou
assay
calcul
use
mcnemer
test
pvalu
consid
statist
signific
season
subtyp
accuraci
rvp
assay
previous
confirm
laboratori
use
convent
rtpcr
cdc
design
specif
primer
follow
sequenc
analysi
total
season
season
strain
identifi
rvp
confirm
appropri
season
subtyp
addit
set
rvp
unsubtyp
influenza
sampl
confirm
novel
test
ny
state
depart
health
inhous
determin
addit
unsubtyp
influenza
strain
novel
influenza
five
season
season
strain
identifi
rvp
test
neg
novel
therefor
base
upon
previou
publish
studi
addit
inhous
data
determin
classif
influenza
strain
rvp
unsubtyp
current
outbreak
highli
predict
novel
therefor
unsubtyp
influenza
strain
identifi
studi
classifi
novel
overal
influenza
identifi
patient
test
number
posit
resultsp
total
test
method
detect
influenza
strain
season
novel
follow
rapid
antigen
test
dfa
rmix
cultur
rvp
rvp
influenza
sampl
novel
season
season
overal
preval
novel
season
season
respect
averag
age
patient
season
year
rang
month
year
season
year
rang
month
year
novel
year
rang
week
year
preval
respiratori
virus
detect
specimen
dfa
andor
cultur
includ
adenoviru
n
hmpv
n
influenza
b
n
parainfluenza
n
parainfluenza
n
parainfluenza
n
rsv
n
rvp
detect
one
multipl
respiratori
virus
influenza
neg
specimen
coinfect
influenza
specimen
tabl
virus
detect
includ
adenoviru
n
coronavirus
n
n
n
hmpv
n
enterovirusrhinoviru
er
group
n
influenza
b
n
parainfluenza
n
parainfluenza
n
parainfluenza
n
parainfluenza
n
rsv
n
er
group
common
dual
infect
seen
influenza
respiratori
virus
overal
rvp
detect
respiratori
viru
sampl
test
tabl
present
sensit
specif
ppv
npv
data
deriv
specimen
test
rapid
antigen
test
binaxnow
b
combin
dfa
rmix
cultur
result
provid
overal
detect
influenza
subtyp
combin
specif
novel
sampl
posit
influenza
novel
n
season
n
season
n
overal
sensit
rapid
test
significantli
lower
p
detect
influenza
subtyp
novel
compar
dfa
respect
rmix
cultur
respect
dfa
significantli
less
sensit
p
rmix
cultur
detect
influenza
subtyp
novel
tabl
present
sensit
specif
ppv
npv
result
one
data
set
binaxnow
test
top
panel
second
data
set
result
obtain
b
test
lower
panel
compar
dfa
rmix
cultur
result
provid
overal
detect
influenza
subtyp
combin
specif
novel
binaxnow
test
signifi
result
identifi
rapid
assay
specif
ppv
test
appear
less
binaxnow
assay
subset
sampl
test
rapid
antigen
dfa
rmix
cultur
rvp
result
four
method
compar
sampl
posit
influenza
novel
n
season
n
season
n
sampl
posit
rmix
subtyp
shown
tabl
sensit
rapid
antigen
test
dfa
significantli
lower
p
detect
influenza
subtyp
respect
novel
respect
compar
rmix
cultur
rvp
detect
influenza
subtyp
respect
detect
novel
respect
studi
evalu
perform
multipl
influenza
detect
method
use
cours
novel
outbreak
new
york
citi
area
period
magnitud
sampl
test
signific
number
novel
sampl
includ
studi
provid
sound
basi
perform
evalu
although
antigen
base
test
requir
littl
technic
skill
rapid
perform
emerg
depart
set
sensit
specif
assay
question
binaxnow
assay
demonstr
poor
sensit
detect
season
influenza
novel
compar
rmix
cultur
respect
b
test
demonstr
better
sensit
detect
season
influenza
novel
compar
rmix
cultur
respect
increas
sensit
b
assay
binaxnow
assay
consist
previou
studi
laboratori
directli
compar
two
test
detect
season
influenza
influenza
b
studi
sensit
b
detect
influenza
significantli
greater
p
sensit
binaxnow
studi
binaxnow
demonstr
better
ppv
detect
influenza
subtyp
combin
novel
b
test
due
fals
posit
b
result
n
test
pediatr
np
wash
earli
outbreak
previou
studi
b
demonstr
high
specif
detect
influenza
ppv
one
fals
posit
influenza
sampl
detect
caus
fals
posit
result
studi
current
known
may
relat
type
sampl
test
presenc
excess
mucou
blood
sampl
addit
studi
laboratori
manufactur
underway
determin
root
caus
fals
posit
influenza
result
addit
extens
head
head
comparison
binaxnow
b
test
conduct
dfa
identifi
season
novel
influenza
posit
sampl
rapid
test
addit
studi
perform
determin
perform
dfa
reagent
manufactur
detect
novel
rmix
cell
shown
accept
cultur
system
detect
novel
expect
rmix
cultur
provid
highest
degre
sensit
among
tradit
test
method
dfa
rmix
cultur
ad
benefit
also
identifi
common
respiratori
virus
includ
adenoviru
hmpv
parainfluenza
virus
rsv
also
circul
influenza
outbreak
overal
rvp
assay
provid
highest
qualiti
result
due
sensit
assay
broad
scope
viral
pathogen
detect
assay
influenza
virus
detect
sampl
test
rvp
compar
rapid
antigen
test
dfa
rmix
cultur
demonstr
previou
studi
addit
sampl
test
studi
rvp
assay
accur
distinguish
season
novel
influenza
subtyp
abil
subtyp
influenza
viru
step
initi
identif
prove
except
use
save
valuabl
laboratori
resourc
time
reflex
second
assay
refer
depart
health
identif
patient
infect
novel
fact
height
outbreak
laboratori
provid
rvp
test
hospit
outsid
health
system
also
act
first
line
triag
local
citi
state
depart
health
addit
due
comprehens
natur
rvp
test
laboratori
also
abl
identifi
viru
es
respons
numer
respiratori
infect
due
influenza
final
comprehens
natur
assay
help
us
better
understand
epidemiolog
novel
infect
signific
mix
viral
infect
move
forward
epidem
continu
ny
citi
area
around
world
extrem
import
keep
health
care
provid
apprais
perform
characterist
diagnost
test
appropri
laboratori
test
perform
appropri
clinic
decis
made
base
upon
accur
reliabl
diagnost
test
ccg
acknowledg
research
fund
diagnost
hybrid
luminex
molecular
diagnost
ccg
member
luminex
scientif
advisori
board
